Medmo
New York, US · Founded 2017 · Delaware corporation · 8 known investors
Medmo manages medical imaging referrals for physicians and health plans, handling patient scheduling, prior authorizations, insurance coordination, and report collection across imaging centers and hospitals nationwide. The platform works with any EMR via e-fax or API and aims to lower imaging spend, improve HEDIS and Star Ratings, and direct patients to in-network facilities across the United States.
Founders & leadership
Board
Investors · 8
Also in the syndicate · 3
Reported raises · per SEC filings
Form D private placements$31.8M disclosed across 10 rounds · 2017–2025
▶$14.6MraisedOct 2025 · 12 investors · OtherRule 506(b)
- Lucas TakahashiExecutive Officer, Director, Promoter
- Gadi PoratDirector
- Robert EpsteinDirector
- Christopher KellyDirector
- Offering amount
- $14.6M
- Amount sold
- $14.6M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.6MraisedFeb 2025 · 11 investors · Other Health CareRule 506(b)
- Lucas TakahashiExecutive Officer, Director
- Christopher KellyDirector
- Gadi PoratDirector
- Offering amount
- $5M
- Amount sold
- $4.6M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedOct 2023 · 13 investors · Other Health CareRule 506(b)
- Gadi PoratDirector
- Christopher KellyDirector
- Lucas TakahashiExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedAug 2022 · 12 investors · Other Health CareRule 506(b)
- Christopher KellyDirector
- Lucas TakahashiExecutive Officer, Director
- Gadi PoratDirector
- Offering amount
- $4M
- Amount sold
- $1.6M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$2.7MraisedAug 2021 · 3 investors · Other Health CareRule 506(b)
- Alex DikmanDirector
- Lucas TakahashiExecutive Officer, Director
- Christopher KellyExecutive Officer, Director
- Offering amount
- $2.7M
- Amount sold
- $2.7M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$3MraisedJan 2021 · 1 investors · Other Health CareRule 506(b)
- Christopher KellyExecutive Officer, Director
- Lucas TakahashiExecutive Officer
- Offering amount
- $4M
- Amount sold
- $3M
- Proceeds to insiders
- $120K
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$70KraisedSep 2019 · 2 investors · Other Health CareRule 506(b)
- Lucas TakahashiExecutive Officer
- Christopher KellyExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $70K
- Proceeds to insiders
- $150K
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$150KraisedMay 2018 · 2 investors · Other Health CareRule 506(b)
- Christopher KellyExecutive Officer, Director
- Offering amount
- $150K
- Amount sold
- $150K
- Minimum investment
- $75K
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Aug 2026Medmo operates a platform that manages medical imaging referrals from order placement through completion. Once an imaging order is placed, the company takes over patient engagement, appointment scheduling, prior authorizations and collection of resulting reports, positioning itself as an extension of the referring provider's care team. Orders and appointment information are consolidated in a single interface with real-time order tracking and configurable alerts.
The company markets to several segments of the imaging ecosystem: physicians (including primary care, urgent care, women's health, virtual care, value-based care and gaps-in-care programs), imaging centers, payers and patients. For imaging centers, a formalized Medmo partnership unlocks automated patient scheduling; for payers, the stated aims are lower imaging spend, improved HEDIS and Star Ratings, and directing volume to preferred in-network facilities. Patients are also offered self-pay options at participating centers.
Medmo describes its model as combining automation with a human care team providing concierge support 24/7 across languages, supported by a proprietary internal task system.
Business model
Medmo inserts itself into the imaging referral workflow between ordering providers, imaging facilities and insurers, taking over scheduling, prior authorization and report retrieval. It serves physician practices, imaging centers and payers, with imaging centers formalizing partnerships to receive automated patient scheduling and payers engaging Medmo to steer volume to preferred in-network facilities.
Traction
Medmo cites reductions of more than 25% in imaging spend, 30% higher referral completion and patient adherence rates, 95% reduction in staff time, and 100% of referrals directed to in-network facilities. Its site references use by thousands of physicians, and testimonials from Sports & Pain Institute of New York City and Essen Healthcare describe exclusive or multi-practice deployments.
▸Full profile — market position, technology, go-to-market, geography
Market position
Medmo positions itself as an intermediary layer for the medical imaging referral market, serving ordering providers, imaging facilities and payers simultaneously and describing itself as AI-powered care coordination for diagnostics.
Medmo emphasizes EMR-agnostic onboarding via e-fax or API with no required integration, access to imaging facilities nationwide without network restrictions including newly opened centers, a human concierge care team available 24/7 in all languages alongside automation, and end-to-end handling of scheduling, prior authorization and report collection rather than a single workflow step.
Technology
The platform works with any electronic medical record system via e-fax or API, so no integration is required to begin using it. It provides real-time order tracking with customizable alerts, a proprietary task system to coordinate internal care teams, and combines automated, AI-supported care coordination with human-in-the-loop staff support.
Go-to-market
Medmo sells directly to practices, imaging centers and payers through a sales team, supported by an online ROI calculator, case studies, articles and whitepapers. Adoption can begin without EMR integration by using e-fax, and testimonials cite practice-wide and multi-site deployments.
Referring physicians and practices across primary care, urgent care, women's health, virtual care and value-based care; imaging centers and hospitals; health plans and payers; and patients receiving imaging referrals, including self-pay patients.
Geography
The company states nationwide United States coverage, offering access to imaging centers and hospitals across the country without network restrictions. Cited users include practices in New York and patients in New Jersey.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 1
by search overlapCompanies competing with Medmo for the same Google search keywords, organic and paid, via search-intersection analysis.
Legal entities · 1
corporate structureIn the news
▸Research sources · 1
primary sources listed
- Medmomedmo.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Medmo do?
- Medmo is a platform that facilitates medical imaging referrals end-to-end for physicians, imaging centers and payers.
- Who are Medmo's investors?
- Medmo's investors include Origin Ventures, W ventures, C2 Ventures, Jerusalem Venture Partners (JVP), Lerer Hippeau.
- How much funding has Medmo raised?
- Medmo has disclosed $31.8M raised across 10 rounds.
- Where is Medmo headquartered?
- Medmo is headquartered in New York, US.



